Table 2.

Treatment-related adverse events (TRAEs) (n=21)

Events	Grades 1–2 (no (%))	Grade 3 (no (%))
TRAE during nCRT
Lymphopenia	7 (33.3%)	14 (66.7%)
Leukopenia	13 (61.9%)	5 (23.8%)
Neutropenia	8 (38.1%)	3 (14.3%)
Esophagitis	8 (38.1%)	0
Anemia	4 (19.0%)	0
Nausea	5 (23.8%)	0
Dermatitis	2 (9.6%)	0
Thrombocytopenia	1 (4.8%)	0
irAEs during neoadjuvant and adjuvant immunotherapy
Hypothyroidism	2 (9.5%)	0
Pneumonia	1 (4.8%)	0
Nausea	1 (4.8%)	0
Diarrhea	2 (9.5%)	0
Transaminitis	1 (4.8%)	1 (4.8%)
Fever	1 (4.8%)	0

irAEs, immune-related adverse event; nCRT, neoadjuvant chemoradiotherapy.;